This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Akebia Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zeeshan Khawaja: Innovator in Therapeutic Methods for Anemia Treatment
Introduction
Zeeshan Khawaja is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of medicine. His work primarily focuses on therapeutic methods for treating anemia, particularly in patients with chronic kidney disease (CKD). With a strong background in research and development, Khawaja has been instrumental in advancing treatment options for this challenging condition.
Latest Patents
Khawaja holds a patent for his invention titled "Therapeutic methods using vadadustat." This innovative approach provides methods for the treatment of anemia in patients suffering from CKD using vadadustat (Compound 1). The methods described in the patent offer alternative dosing regimens for patients with anemia. Furthermore, these methods are suitable for patients transitioning from previous anemia treatments, including erythropoietin stimulating agents (ESA), as well as those undergoing dialysis or having specific hemoglobin (Hb) levels.
Career Highlights
Zeeshan Khawaja is currently associated with Akebia Therapeutics, Inc., where he continues to work on developing effective treatments for anemia. His expertise in therapeutic methods has positioned him as a valuable asset in the medical research community. Khawaja's dedication to improving patient outcomes through innovative solutions is evident in his work and contributions to the field.
Collaborations
Throughout his career, Khawaja has collaborated with esteemed colleagues, including Steven Burke and Ajit Chavan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in therapeutic methods.
Conclusion
Zeeshan Khawaja's contributions to the treatment of anemia in CKD patients through his innovative patent demonstrate his commitment to improving healthcare. His work at Akebia Therapeutics, Inc. and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile